Coya Therapeutics, Inc. (COYA)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Coya Therapeutics, Inc.. Most notable: 2026-08-07: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-18 | GOLDSTEIN DOV A MD | director | M | 17,557 | 1.09 | $19,137 |
| 2025-08-18 | GOLDSTEIN DOV A MD | director | M | 17,557 | 1.09 | $19,137 |
| 2024-11-14 | SNYDER DAVID S | officer | P | 1,800 | 7.19 | $12,942 |
| 2024-11-14 | SNYDER DAVID S | officer | P | 1,800 | 7.19 | $12,934 |
| 2024-11-13 | Swaminathan Arun | director | P | 5,000 | 7.36 | $36,800 |
| 2024-11-13 | Swaminathan Arun | director | P | 5,000 | 7.36 | $36,797 |
| 2024-11-11 | Grossman Fred | officer | P | 2,710 | 7.37 | $19,973 |
| 2024-11-11 | Swaminathan Arun | director | P | 5,000 | 7.34 | $36,700 |
| 2024-11-11 | Grossman Fred | officer | P | 2,710 | 7.37 | $19,973 |
| 2024-11-11 | Swaminathan Arun | director | P | 5,000 | 7.34 | $36,689 |
| 2023-08-22 | Lee Ann | director | P | 1,000 | 3.62 | $3,620 |
| 2023-01-03 | Berman Howard | director | P | 10,000 | — | — |
| 2023-01-03 | Lee Ann | director | P | 10,000 | — | — |
| 2023-01-03 | Lee Ann | director | C | 6,479 | 4 | $25,916 |
| 2023-01-03 | Hepner Adrian | officer | P | 10,000 | — | — |
| 2023-01-03 | Garren Hideki | director | P | 2,000 | — | — |
| 2023-01-03 | SNYDER DAVID S | officer | P | 7,000 | — | — |
| 2023-01-03 | Villalobos Anabella | director | P | 10,000 | — | — |
| 2023-01-03 | GOLDSTEIN DOV A MD | director | P | 10,000 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-15 8-K
- 2026-08-11 10-Q
- 2026-08-11 8-K
- 2026-08-07 8-K/A
- 2026-07-27 SCHEDULE 13G/A
- 2026-06-25 8-K
- 2026-05-13 ARS
- 2026-05-13 DEFA14A
- 2026-05-13 DEF 14A
- 2026-05-12 8-K
- 2026-05-12 424B5
- 2026-05-12 10-Q
- 2026-05-12 8-K
- 2026-04-09 4
- 2026-04-09 3
- 2026-04-02 8-K
- 2026-03-20 EFFECT
- 2026-03-20 424B3
- 2026-03-19 CORRESP
- 2026-03-19 UPLOAD